Antiplasminic agent Transamin 250mg (10 blisters x 10 capsules/box)
Transamin 250mg inhibits the action of plasmin and shows antihemorrhagic effects.
Transamin 250mg inhibits the action of plasmin and shows antihemorrhagic effects.
- Bleeding tendencies in which systemic hyperfibrinolysis is considered to be involved: leukemia, aplastic anemia, purpura, abnormal bleeding during or after operation. - Abnormal bleeding in which local hyperfibrinolysis is considered to be involved: pulmonary hemorrhage, epistaxis, vaginal hemorrhage, renal bleeding, abnormal bleeding during or after prostate surgery.
- Patients receiving thrombin (See "Drug Interactions")
- Patients with a history of hypersensitivity to any of the ingredients of the product.
The usual adult dosage for oral use is 750 to 2000mg of Tranexamic acid (as the base) daily in 3 or 4 divided doses.
The dosage should be adjusted to individuals according to the patient's age and symptoms.
- Patients with thrombosis.
- Patients with consumption coagulopathy.
- Reduce dosage for patients with severe renal failure.
- Patients with a history of hypersensitivity to the product.
Store at temperature below 30°C, protect from light.